Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing NaN - NaN of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

Mantle Cell Lymphoma Trial in United States (Venetoclax, Bendamustine, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Urbana, Illinois
  • +9 more
Nov 10, 2022

Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

Withdrawn
  • Asymptomatic COVID-19 Infection Laboratory-Confirmed
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 2, 2022

Collecting and Storing Tissue Samples From Rare or Cutaneous

Active, not recruiting
  • Adult Immunoblastic Lymphoma
  • +12 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +129 more
Mar 23, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
Has Results
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

Completed
  • Chronic Lymphoid Leukemia
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 28, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Rochester (biological, procedure,

Completed
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • +15 more
  • dendritic cell vaccine therapy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 13, 2020

Mantle Cell Lymphoma Trial in Worldwide (lenalidomide)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Little Rock, Arkansas
  • +69 more
Dec 11, 2018

DLBCL, Transformed Follicular Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Alisertib (MLN8237), Rituximab, Vincristine)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Alisertib (MLN8237)
  • +2 more
  • Tucson, Arizona
  • +24 more
Feb 27, 2018

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +127 more
Jan 8, 2018

CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in

Completed
  • CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma
  • +9 more
  • Scottsdale, Arizona
  • +9 more
Jan 29, 2018

Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in Tucson, Rochester (Imexon)

Completed
Has Results
  • Follicular Lymphoma
  • +6 more
  • Tucson, Arizona
  • +1 more
Dec 4, 2015

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Australia, Canada, United States (Bendamustine, Rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +42 more
Apr 7, 2014

Mantle Cell Lymphoma Trial in India, United States (P276-00)

Terminated
Has Results
  • Mantle Cell Lymphoma
  • Phoenix, Arizona
  • +19 more
Jun 20, 2012

Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Omaha, Nebraska
  • +4 more
Apr 19, 2012

Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)

Completed
  • Follicular Lymphoma
  • +4 more
  • Birmingham, Alabama
  • +10 more
Jun 24, 2011

Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

Completed
  • Mantle Cell Lymphoma
  • VELCADE TM (bortezomib) for Injection
  • Birmingham, Alabama
  • +34 more
Feb 7, 2008